论文期刊

取消

高级检索

检索历史清除

首页> Pathology oncology research : POR> Overexpression of PELP1 in Lung Adenocarcinoma Promoted E<sub>2</sub> Induced Proliferation, Migration and Invasion of the Tumor Cells and Predicted a Worse Outcome of the Patients.

Overexpression of PELP1 in Lung Adenocarcinoma Promoted E<sub>2</sub> Induced Proliferation, Migration and Invasion of the Tumor Cells and Predicted a Worse Outcome of the Patients.

导出 OA

翻译打印收藏纠错

第一作者： Dongmei,Zhang

第一单位： Department of Pathology, Harbin Medical University-Daqing, Daqing, China.

作者： Dongmei,Zhang ^[1] ; Jiali,Dai ^[1] ; Yu,Pan ^[2] ; Xiuli,Wang ^[1] ; Juanjuan,Qiao ^[1] ; Hironobu,Sasano ^[1] ; Baoshan,Zhao ^[3] ; Keely M,McNamara ^[1] ; Xue,Guan ^[3] ; Lili,Liu ^[1] ; Yanzhi,Zhang ^[1] ; Monica S M,Chan ^[1] ; Shuwen,Cao ^[3] ; Ming,Liu ^[4] ; Sihang,Song ^[1] ; Lin,Wang ^[5]

作者单位： Department of Pathology, Harbin Medical University-Daqing, Daqing, China. ^[1] Traditional Psychological Unit, The Third Hospital of Daqing, Daqing, China. ^[2] Department of Pathology, Tohoku University School of Medicine, Sendai, Japan. ^[3] Department of Pathology, Daqing Oilfield General Hospital, Daqing, China. ^[4] Department of Pathology, The Fifth Affiliated Hospital of Harbin Medical University, Daqing, China. ^[5]

关键词 estrogen glutamic acid-leucine-rich protein 1 lung adenocarcinoma proline-tumor progression

主题词细胞系, 肿瘤(Cell Line, Tumor);细胞运动(Cell Movement);细胞增殖(Cell Proliferation);辅阻遏蛋白质类(Co-Repressor Proteins);雌二醇(Estradiol);雌激素受体α(Estrogen Receptor alpha);雌激素受体β(Estrogen Receptor beta);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);淋巴转移(Lymphatic Metastasis);男(雄)性(Male);中年人(Middle Aged);预后(Prognosis);存活率(Survival Rate);转录因子(Transcription Factors)

DOI 10.3389/pore.2021.582443

PMID 34257530

发布时间 2021-12-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Pathology oncology research

582443页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷